Latest News and Press Releases

Data published in Frontiers in Immunology show a robust safety profile and rapid resolution from ARDS and parallel resolution of inflammation markers and elevated cytokines/chemokines, as well as...

New York, United States , April 03, 2023 (GLOBE NEWSWIRE) -- The Global Acute Respiratory Distress Syndrome Market Size to grow from USD 980.4 million in 2021 to USD 2,137.6 million by 2030, at a...

Pune, Jan. 18, 2023 (GLOBE NEWSWIRE) -- According to the latest report published by Growth Plus Reports, the global acute respiratory distress syndrome therapeutics market is expected to clock US$...

Isle of Man, Dec. 06, 2022 (GLOBE NEWSWIRE) -- The Douglas Insights Engine is the world’s first market comparison engine. People from all industries, including market analytics, research, business,...

Brazil Phase 2 Pivotal clinical trial of COVI-MSC is now authorized to proceed.The study will compare therapy using mesenchymal stem cells to placebo (and standard of care) in 100 COVID-19 patients...

All nine patients with acute respiratory failure due to COVID-19 discharged from hospital within days after 3rd COVI-MSC infusionPreparations are ongoing for initiating Phase 2 placebo-controlled...

First three patients discharged from Hospital ICU within 8 days from initial IV administration  No infusion-related adverse events noted for any patient treated to date  SAN DIEGO, Jan. 26, 2021 ...

SAN DIEGO, Oct. 12, 2020 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (Nasdaq: SRNE, "Sorrento") announced today that it has entered into an exclusive license agreement with Personalized Stem...

Pune, Sept. 24, 2020 (GLOBE NEWSWIRE) -- Advancements in stem cell research is a major driving factor for the global acute respiratory distress syndrome treatment market growth. According to the...

First participants treated at the University of Miami Miller School of Medicine with intravenous RLF-100Clinical trial to enroll 144 patients total with expansion to additional sites including the...